跳至主要内容
临床试验/IRCT20120225009124N4
IRCT20120225009124N4招募中2 期

Efficacy of different methods of administeration of combination regiemn including dexamethasone, IV-IG and Interferone beta for treatment of patients with severe COVID-19: a randomized controlled trial

Gorgan University of Medical Sciences0 个研究点目标入组 105 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
105

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 70 years(—)
性别
All

入选标准

  • Age 18-70 years
  • Sever COVID19 disease with the following criteria: SPpO2 below 90% and respiratory rate higher 24 per minute; Involvement of more that 50% of lung in CT-scan

排除标准

  • Need for intubation at the time of admission
  • Contraindication of corticosteroids, IV IG and interferon beta
  • Pregnancy, lactation

研究者

发起方
Gorgan University of Medical Sciences

相似试验